# Some US employers to drop coverage of GLP-1 obesity drugs in 2027 as use increases

> **Open Intelligence Dossier** · First detected: 2026-06-11 17:26 UTC · Category: Business

## Executive Summary
US employers may halt GLP-1 drug coverage in 2027 amid rising costs and usage spikes

## Intelligence Brief
A growing number of US employers are preparing to exclude GLP-1 weight-loss medications—such as Ozempic and Wegovy—from health plans starting next year. Coverage from *Forbes*, *The Wall Street Journal*, and *Reuters* highlights concerns over escalating prescription demand, which has outpaced budget projections. Some state-level discussions, including California’s consideration for public employees, signal broader policy shifts ahead.


Business and healthcare outlets—including *Modern Healthcare*, *Fierce Healthcare*, and *Yahoo Finance*—emphasize the financial strain on pharmacy benefit managers (PBMs) and corporate insurers. Reports note that employers are reassessing pharmacy benefits, with some exploring tiered coverage or outright exclusions. Analysts cited in *Fierce Healthcare* suggest payers may adopt stricter criteria for GLP-1 prescriptions, though no uniform policy has been announced.


Watch for potential legal challenges from patients or advocacy groups if exclusions proceed. Pharmaceutical manufacturers may respond with pricing adjustments or alternative reimbursement models, though no such moves have been reported yet.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| Forbes | Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying | [Source Link](https://news.google.com/rss/articles/CBMirwFBVV95cUxQTmlxWHhDRV9NY1NVZ0t0Vi1ZZEwzNFRmc2F3TlBKMnVhWEYtRFlyUF80WHpGTE5RV2hBUThUVHhIZ3JXbUtXZk5hTExISnFOUHR2QVhDcW5rUE1qUm8wUnk1NnlRYzNKbWRZcEdPSWhHems5Wlk2ZFIxNVE0ZC1zY2xvQ0Q5d0psZ1h6bmY0VXJCWklHS3d0U3MwZVhRWWZaTno2akY2Qk0yTjJNS3Ew?oc=5) |
| qz.com | Some employers are dropping weight loss drug coverage as use surges | [Source Link](https://news.google.com/rss/articles/CBMifEFVX3lxTE9HS3F0WFRFTWNrcERGUmo2YVJKRVJaZ0dQWTV5Y3hQSjRxRWxmRERUSV9haHRzSWRMZFBEOW1xTXBEeDRHSlc4TGNVZHpLTkUtSnpQQTJOTkM4UGRIbXo0RDQ2d3ZtS0Z2LU9xNVJHZXY0TzZ4U0dOTFBGekI?oc=5) |
| WSJ | Your Weight-Loss Drugs Are Next on the Corporate Chopping Block | [Source Link](https://news.google.com/rss/articles/CBMiqgFBVV95cUxPZUZmQ2swQzFSVnhwQW5LRC1TV3BLUFk2c3ZPNDZxdmNKaURyRnAzdnRTbzI4QS05Nl9KV2ZVeXJfRFlBcEhESDM2T19uMVFUQm9lclNXNlZGMXRPM3ZpaU5sQVVNZXp1T1dMVW02ellwdFQwNlZsR3E4YmdjMy16eWxpOVJQME5JSngwdURQQjZvQkFWYVZxZFFkeXB2VXlFdGlFLVFvY0FRdw?oc=5) |
| CalMatters | Can California afford to cover Ozempic for public employees? | [Source Link](https://news.google.com/rss/articles/CBMibkFVX3lxTE02QmlaOHB5d09mS2JUdEU3czNuZl9jZDlYcGhMZ0pscDM4Z2dZYTlhN210OGZTUlZvRkRIeU4wV2xTX2lzbG50VFdLTmxBQ2RSMU10enlmT1FNZUJrbUVVR0Ruek0yWjZkTFh4VDhR?oc=5) |
| Yahoo Finance | U.S. employers dropping GLP-1 weight loss drug coverage in 2027 | [Source Link](https://news.google.com/rss/articles/CBMimwFBVV95cUxNbVVGNVcySnhQWFFTMGFjZTVleXR2ZDY4RFo4eXp6ZWdNQUlZRW5YTHpIbkpsR3dMYXBBNE82TVFCeXpfTnh0WTV5OEQxZmc3UEd6UF91bWlhMmJ3T1hoOXJYTDZabU5Mdm5HNUR4anAyY0lkNi11Nk5nZUVBWTFUSFRrdnZQNHlNWGZVUFhIUEJMQTI1Z0RXR2ZRbw?oc=5) |
| Modern Healthcare | Employers are rethinking pharmacy benefits: 5 things to know | [Source Link](https://news.google.com/rss/articles/CBMigwFBVV95cUxNaHIyREpxcFhkWHRJVnRBbkJaWkc0Q3M2Z3JlQnhlNU1oSzkxZGhZMU5iSGY2MlZiaVVWX1I2REEyOUp3bm9wNmZYd3VWVk9fZVRYVTJaWWNqWUl3OWNnQk5YajFPZGRVeXN5cFI1aC1ITkNrWTFUeU9ETE1NU1gzeUhKaw?oc=5) |
| Fierce Healthcare | PSG report examines payers and employers’ attitudes towards GLP-1 coverage, unbundling’ PBM models | [Source Link](https://news.google.com/rss/articles/CBMiywFBVV95cUxQQlBDUHl5YU9wYUZuRWxTdnJEQ09TVkRsTmk5WlJMT2xmaUtMWXVpQkViVmN5NEwtc2VuVnRvRm9FdDEzMzJIbElqeXJTdWd5eURaODVXUUV0Mzc2YUZubFo1YmJTTExub29CUE02Vk5pOXJIZ3Z1MjYyVlpxLVBlMmU3eG1LX0duVDVJQWhFbW9rQVZ3LUhoY2g0YmJ2WWVHRXhnMTIxemNXSERLMjhzZkxnMEdIenlZS1NyUTFaUkJ6dkVoV1ZNRm43aw?oc=5) |
| Reuters | Some US employers to drop coverage of GLP-1 obesity drugs in 2027 as use increases | [Source Link](https://news.google.com/rss/articles/CBMiwAFBVV95cUxPdktJUEg1UWw5cXJVWW5pc01DZTBXdXhvRTMxZ2sxZTg1a2VsbU1TNWVCWFJCNWJlWmc4QzdQUlBNUkFWWjBCWjB3NWctMlpYcmhwMnQyb2FjTjVRMXFQYjlkSzhWQ0dUVFhfRk5hZEFZTjdRSXNKQ2QxQWQ0V0xYR2hHckdFZm45Z0tDR1RDVmViXzZZLTRLRUtXQV9fcmlRaU9XNzREUFI5bWI0VlVxOF9yUHlPWTB0ZGl0djRZRkU?oc=5) |

---
*Canonical Source: https://pulse.byoviral.com/trend/2026-06-11/some-us-employers-to-drop-coverage-of-glp-1-obesity-drugs-in-2027-as-use*